16 March 2007
Donation and transplantation in Latvia – 2006
R. Rozental, J. Bicans, V. Shevelev, S. TrushkovAnn Transplant 2007; 12(1): 37-39 :: ID: 496346
Abstract
The 75 kidney transplant operations (32.6 per million population per year) and 2 heart transplant operations were performed in 2006 in Latvia. This represents a slight decrease of 3% compared to 2005. 86 kidneys were procured from 43 deceased donors. There were 46% donors with brain death and 54% non-heart-beating donors among them. During last decade the donor rate increased from 10.9 per million population in 1996 to 18.7 per million population in 2006. In our center patient survival was 93.2% at 1 year and 87.4% at 5 years, and graft survival was 84.5% at 1 year and 72.3% at 5 years. Such transplantation activity ensures mean waiting time of 6–7 months for patients accepted for kidney transplantation.
Keywords: Organ Donation, Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






